Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses
about
Perspectives for therapeutic HPV vaccine developmentPerspectives for preventive and therapeutic HPV vaccines.Immunotherapy for cervical cancer: Research status and clinical potentialPerspective for prophylaxis and treatment of cervical cancer: an immunological approach.The future of vaccines for cervical cancer.Virus-Like Particles Harboring CCL19, IL-2 and HPV16 E7 Elicit Protective T Cell Responses in HLA-A2 Transgenic MiceDisrupted adenovirus-based vaccines against small addictive molecules circumvent anti-adenovirus immunity.Preventive and Therapeutic Vaccines against Human Papillomaviruses Associated Cervical CancersHPV Vaccines: today and in the Future.Therapeutic vaccines against human papillomavirus and cervical cancer.Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice.Therapeutic live vaccines as a potential anticancer strategy.Current state in the development of candidate therapeutic HPV vaccinesThe current state of therapeutic and T cell-based vaccines against human papillomaviruses.The Journey of Virus Engineered Dendritic Cells From Bench to Bedside: A Bumpy Road
P2860
Q28069272-AD52F503-0A88-4128-B612-44B716A37796Q34011494-2907067E-DDD7-47A9-8E10-0FE0E30E6573Q34033763-D0C57169-F547-4D9D-9C3B-00114FA02D67Q34181909-2023FC26-1A29-4889-BE4C-24836E4815F3Q35805491-35F26A57-C97D-496C-81E8-547EBC36FE9EQ36540598-95A12CFD-6F81-4998-9B5C-28D68B5FA31CQ36562614-1BABAFD1-023C-4029-9287-1B12005BD0CBQ36652548-4CC096A0-2FC7-40A6-B51B-BB65D69AC5A1Q36976268-ABB1D35C-D688-4B2D-98E4-EC5C226B3864Q37418916-09BD62EC-2BB5-48E7-B67F-BD555B7C829CQ37845082-EAA81F60-EAD6-47A9-B83A-E050BFCFF9E7Q38011653-49C019C9-0A51-4E97-9979-88714F60F2C6Q38743922-3CBFA4C3-FE13-45C4-92F3-15F682FE7F4CQ39033576-C39A240C-BD41-4C32-9687-D82C0ED07C3CQ58750585-C0F87156-C1AC-4B75-98A6-AB6CA4FD4267
P2860
Low-dose adenovirus vaccine encoding chimeric hepatitis B virus surface antigen-human papillomavirus type 16 E7 proteins induces enhanced E7-specific antibody and cytotoxic T-cell responses
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Low-dose adenovirus vaccine en ...... and cytotoxic T-cell responses
@ast
Low-dose adenovirus vaccine en ...... and cytotoxic T-cell responses
@en
Low-dose adenovirus vaccine en ...... and cytotoxic T-cell responses
@nl
type
label
Low-dose adenovirus vaccine en ...... and cytotoxic T-cell responses
@ast
Low-dose adenovirus vaccine en ...... and cytotoxic T-cell responses
@en
Low-dose adenovirus vaccine en ...... and cytotoxic T-cell responses
@nl
prefLabel
Low-dose adenovirus vaccine en ...... and cytotoxic T-cell responses
@ast
Low-dose adenovirus vaccine en ...... and cytotoxic T-cell responses
@en
Low-dose adenovirus vaccine en ...... and cytotoxic T-cell responses
@nl
P2093
P2860
P921
P1433
P1476
Low-dose adenovirus vaccine en ...... and cytotoxic T-cell responses
@en
P2093
Andrés Báez-Astúa
Elsa Herráez-Hernández
Hilda A Pasolli
Natalio Garbi
Victoria Juárez
P2860
P304
12807-12817
P356
10.1128/JVI.79.20.12807-12817.2005
P407
P577
2005-10-01T00:00:00Z